Joel Greenblatt’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Sell
2,674
-13,192
-83% -$1.17M ﹤0.01% 1780
2026
Q2
$1.52M Buy
15,866
+6,386
+67% +$655K ﹤0.01% 1235
2026
Q1
$1.03M Sell
9,480
-6,547
-41% -$624K ﹤0.01% 1294
2025
Q4
$1.3M Buy
16,027
+9,275
+137% +$798K ﹤0.01% 1179
2025
Q3
$591K Buy
+6,752
New +$603K ﹤0.01% 1348
2022
Q1
– Sell
-5,280
Closed -$265K – 1188
2021
Q4
$265K Buy
+5,280
New +$273K 0.01% 984
2018
Q2
– Sell
-7,053
Closed -$256K – 967
2018
Q1
$256K Buy
+7,053
New +$244K ﹤0.01% 850

Other funds holding LMAT

Joel Greenblatt's LMAT Position: Q3 2026 in Review

Joel Greenblatt reduced its LeMaitre Vascular (LMAT) stake by 83% in Q3 2026, selling an estimated $1.17M and leaving 2,674 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Joel Greenblatt first reported a position in LMAT in Q1 2018 and has held it in 7 quarters since. The position peaked at $1.52M in Q2 2026. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Joel Greenblatt held 2,674 shares of LeMaitre Vascular worth $221K as of Q3 2026.
  • Joel Greenblatt sold 13,192 LeMaitre Vascular shares in Q3 2026, an estimated $1.17M.
  • LeMaitre Vascular made up ﹤0.01% of Joel Greenblatt's portfolio in Q3 2026, its #1780 holding.
  • Joel Greenblatt first reported a position in LeMaitre Vascular in Q1 2018 and has held it in 7 quarters since.
  • Joel Greenblatt's LeMaitre Vascular position peaked at $1.52M in Q2 2026.
  • 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Gotham Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.